Northwestern Medicine scientists have discovered increased immune cell activity in Merkel cell carcinoma tumors, which could help predict treatment response in patients and inform the development of new targeted therapies, according to findings published in the journal Cancer Discovery.
Browsing: Melissa Rohman
Northwestern Medicine scientists have discovered that mitochondria are not necessary for the proliferation of immune cells called microglia, but do help them respond to demyelinating injury, according to a study published in Nature Metabolism.
Three Feinberg medical students have been named 2024-2025 Chicago Area Schweitzer Fellows, a program to support fellows’ design and implementation of innovative projects to address the health needs of underserved Chicago communities.
Proteomic analysis of blood samples from pregnant individuals did not improve risk prediction of hypertensive disorders of pregnancy compared to current methods, underscoring the demand for more accurate prediction tools, according to findings published in JAMA Cardiology.
Adolescents with severe obesity who received meal replacement therapy plus financial incentives experienced a greater reduction in body mass index compared to those who received meal replacement therapy alone, according to recent findings published in JAMA Pediatrics.
Subcutaneous delivery of an anti-TNF inhibitor therapy improved remission rates compared to placebo in patients with moderate-to-severe Crohn’s disease and ulcerative colitis who previously completed intravenous anti-TNF therapy, according to clinical trial results published in the journal Gastroenterology.
Northwestern Medicine investigators have discovered novel protein mechanisms that promote the rapid spread of Vibrio vulnificus, a rare but lethal bacteria that can cause vibriosis and sepsis, according to findings published in Proceedings of the National Academy of Sciences.
Kranti Rumalla, a second-year medical student at Feinberg, was the lead author of a study that found racial disparities among patients who were disenrolled from Medicaid coverage after the end of the COVID-19 Public Health Emergency.
Patients with immunotherapy-resistant bladder cancer who received a novel combination treatment demonstrated improved response to treatment, according to a recent study published in Nature Medicine.
A pair of recent studies led by Joseph Mazzulli, PhD, have uncovered previously unknown cellular mechanisms involved in neuronal protein aggregation and misfolding, key characteristics of Parkinson’s disease, which may serve as therapeutic targets.